Low Dose Naltrexone Book by Joseph Wouk

Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 2009/04/25 - Updated: 2016/11/10
Topic: Disability Publications - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: The book Google LDN written by Joseph Wouk looks at Low dose Naltrexone for Multiple Sclerosis and autoimmune diseases.

Introduction

The only way to find out about Low-dose Naltrexone (LDN) is to Google the word itself; thus the title of Joseph Wouk's book - Google LDN.

Main Item

The only way to find out about Low-dose Naltrexone (LDN) is to Google the word itself; thus the title of Joseph Wouk's book - Google LDN

About Joseph Wouk and the Google LDN Book

Joseph explains how Low-dose Naltrexone works its magic by causing the human body to produce 2 to 3 times the normal amount of endorphins, it restores the human immune system to its full operating condition. This is why it works not only for Multiple Sclerosis (MS), but for other serious diseases such as Cancer, AIDS, Parkinson's, Autism, Chron's Disease, and just about every other Immune system related disease.

Google LDN is Wouk's attempt at Dana Paramita, which is the Buddhist version of Christian "good works". Google LDN will have you both laughing and crying through the first part of the book and you'll be inspired by the second part. Told with humor and honesty, Joseph Wouk captivates the reader through his thought processes as he watches his own mind dissolve from the subcortical dementia caused by MS.

Diagnosed with Progressive Relapsing Multiple Sclerosis, Joseph Wouk refuses to accept the doctor's opinion that there is nothing more to be done for his medical condition. He plans to go to the Amazon to try to cure himself with a Shaman's ayahuasca ceremony. Just before he is scheduled to leave for Peru, all of his MS symptoms suddenly disappear after taking LDN. A man who refuses to give up in the face of insurmountable odds ends up completely healed despite the hopelessness that western medicine tells him he faces.

From the back cover of Google LDN

Diagnosed with Progressive Relapsing Multiple Sclerosis, Joseph Wouk, youngest son of novelist Herman Wouk refuses to accept the doctors opinion that there is nothing more to be done for his medical condition. He plans to go to the Amazon to try to cure himself with a Shamans ayahuasca ceremony. The book begins as a journal entitled, PLACEBO A Rationalist Seeks a Miracle Cure. Wouk, a hardened western rationalist has no patience for spooks or spirits or any other new age wishful thinking. His plan is to try to delude himself with psychedelics into thinking he is cured - Thereby activating the placebo effect to cure himself for real. He covers all the bases: From Buddhism to Judaism. From quantum physics to Godels incompleteness theorem. From alternative medicine to the Metaphysics of Quality.

Editorial:

As with most medications, there can be side effects to contend with. From observations, the most common is initial sleep disturbance, and; in the case of some diseases such as progressive forms of Multiple Sclerosis, there's also a possibility of exacerbation in the first six months of treatment.

I've also learned from observations that those who don't succeed with LDN often have a long and recent history of medication reliance, or have deferred making complementary lifestyle changes. In particular, abrupt cessation of opioid-based (narcotic) pain medications, steroids or other immune system suppressants following a lengthy period of reliance can result in withdrawal symptoms or rebound effects, and hence, abandonment of LDN as a treatment option.

This is an understandable 'catch 22'. We want the 'high impact' health fix for many reasons: We can't afford time off work or for our boss to discover our health's been compromised, or we have families relying on us to care for them - and so we lean on the health solution that helps us get on with our day-to-day lives with the least interruption - but not necessarily in the least invasive way.

Clinical trials of LDN are needed, but as some would need to run for six to twelve months or longer, they'd be costly. Naltrexone has long been 'off-patent', so the pharmaceutical companies that initiate clinical trials are unlikely to perceive this particular unmet market need as potentially profitable and worthy of investment.

Commercialism can benefit markets - but there are distinct areas where commercial markets should not dominate, infiltrate, conflict, or otherwise influence to the detriment of the greater public good. Indeed, the story behind LDN infers the health market scales have long been tipped too far in favor of commercialism and are in need of re-balancing.

'Optimum quality of life' is a basic human right that should stand tall, above all other rights. It is sacrosanct and must therefore be protected from the taint of 'conflict of interest'. Societies thrive in an environment of fair play and balanced needs, and there is no greater need for fair play and balance than in health.

pandora.nla.gov.au/pan/87844/20101009-0233/www.ldnresearchtrustfiles.co.uk/docs/2010.pdf

Author Credentials: Ian was born and grew up in Australia. Since then, he has traveled and lived in numerous locations and currently resides in Montreal, Canada. Ian is the founder, a writer, and editor in chief for Disabled World. Ian believes in the Social Model of Disability, a belief developed by disabled people in the 1970s. The social model changes the focus away from people's impairments and towards removing barriers that disabled people face daily. To learn more about Ian's background, expertise, and achievements, check out his bio.